Sermorelin Testimonials: How to Read Them

Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Sermorelin testimonials are personal stories, and a personal story cannot show that sermorelin caused a change. The Federal Trade Commission (FTC) says in its Health Products Compliance Guidance that anecdotal evidence about individual consumer experiences, including surveys of consumer experiences, is never sufficient to substantiate claims about the effects of a health product. This page explains how to read sermorelin testimonials and before and after claims, what the FTC and FDA say about them, what an independent 2026 review found about the human evidence, and which questions to ask a clinic first. My own medicine story, a GLP-1 started in May 2024, is on the About us page.

For the basics first, see my sermorelin therapy overview.

Table of Contents

What can a sermorelin testimonial tell you?

It can tell you what one patient reported, such as sleeping better or finding the injection easy. It cannot tell you why that happened. A person may also change sleep habits, food or exercise at the same time, and a testimonial rarely says so.

The National Center for Complementary and Integrative Health (NCCIH) describes the placebo effect as a beneficial health outcome that results from a person’s anticipation that an intervention will help (page last updated January 2020). NCCIH calls the randomized, placebo-controlled trial the gold standard for testing an intervention, because comparing a treated group with a placebo group shows whether changes come from the treatment or occur by chance. A testimonial has no comparison group.

Do testimonials match what trials find?

Not in the one comparison I can cite. It looked at commercial weight loss programs, not sermorelin, but the pattern is a useful warning. A content analysis in Obesity, Commercial Programs’ Online Weight-Loss Claims Compared to Results from Randomized Controlled Trials, reviewed the home pages and testimonials on 24 randomly selected program sites. Across the programs, the typical (median) story featured a loss of 10.7 to 49.5 kg, depending on the program. Only 10 of the 24 programs had eligible randomized trials, and the stories on their sites beat what trial participants achieved. Among programs with trials, most gave a disclaimer that results were not typical or listed a range of typical weight loss.

What do sermorelin reviews on seller websites leave out?

They usually leave out the comparison group, the baseline and the product details. For example, on its home page, read on October 26, 2026, the telehealth company GobyMeds says in its FAQ that sermorelin is a peptide therapy that stimulates natural growth hormone release and that it “may support energy, fat metabolism, sleep, and recovery.” The same FAQ says sermorelin is available for off-label use via prescription for anti-aging and vitality purposes, and the page says treatment is only provided if a licensed provider determines it may be appropriate after review. Those are company statements, not trial results.

Compare that with the independent evidence. A 2026 narrative review in Frontiers in Endocrinology, The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis, says clinically meaningful benefits in healthy people remain uncertain because the human evidence base is limited and largely indirect. The authors reported no commercial or financial relationships that could be construed as a conflict of interest.

What does the FTC say about testimonials and health claims?

Three FTC documents change how you should read a patient story.

Are fake or paid sermorelin reviews against the rules?

Yes, when they are fake or when a connection is hidden. The FTC’s Consumer Reviews and Testimonials rule, which went into effect on October 21, 2024, bars businesses from writing, creating or selling fake or false consumer reviews and testimonials. It requires clear and conspicuous disclosure of certain insider relationships. It also bars false accusations against a reviewer and intimidation or unfounded legal threats meant to remove or change reviews. The rule allows courts to impose civil penalties for knowing violations (FTC questions and answers on the rule, read October 26, 2026).

What do the Endorsement Guides say about typical results?

The FTC’s Endorsement Guides questions and answers say an endorsement must reflect the honest opinion of the endorser, and a connection between endorser and marketer that a significant minority of consumers would not expect, and that would affect how they weigh the endorsement, should be disclosed clearly and conspicuously, usually when the endorser has been paid or given something of value. If an endorser’s result is exceptional, the advertiser needs proof it represents what people will generally achieve, or the ad must make clear what the generally expected results are. The FTC’s example is a person who claims to have lost 20 pounds in two months (Endorsement Guides: What People Are Asking, read October 26, 2026).

Does a “results not typical” note fix a dramatic story?

No. The Health Products Compliance Guidance says testimonials that report results more dramatic than users can generally expect are likely to be deceptive, and that disclaiming them with a statement like “Results not typical” does not cure the deception. The same guidance applies a competent and reliable scientific evidence standard to health claims, and it says health benefits generally need randomized, controlled human clinical testing to meet that standard (FTC Health Products Compliance Guidance, read October 26, 2026).

Is sermorelin FDA approved, and why does that matter for reviews?

Sermorelin acetate, a growth hormone releasing hormone peptide, was once approved as the brand Geref, but those approvals ended in 2009. A Federal Register notice from March 4, 2013 says Geref 0.5 mg and 1.0 mg vials (NDA 20-443, initially approved September 26, 1997) were indicated for idiopathic growth hormone deficiency in children with growth failure, and the 0.05 mg ampule (NDA 19-863, initially approved December 28, 1990) was indicated for evaluating the pituitary gland’s ability to secrete growth hormone. The manufacturer, EMD Serono, notified the FDA in 2008 that it was discontinuing the products and asked for withdrawal of the applications, and the FDA announced it was withdrawing approval effective June 18, 2009. The FDA also determined that the products were not withdrawn for reasons of safety or effectiveness.

Two points follow. The approved uses were diagnostic testing and a pediatric growth condition, not anti-aging, body composition or weight loss. And what a patient receives today is a separate question from Geref. The FDA states that compounded drugs are not FDA-approved and that it does not verify the safety, effectiveness or quality of compounded drugs before they are marketed (FDA compounding questions and answers, content current as of September 16, 2025). If a testimonial does not say who made the product, you cannot tell what the writer received. I cover the access side in my guide on how to get sermorelin.

Regulators also single out some peptides used in compounding. The FDA’s page on bulk drug substances that may present significant safety risks lists the peptides GHRP-2, GHRP-6 and ipamorelin acetate in category 2 and cites concerns such as immunogenicity and peptide-related impurities (content current as of April 22, 2026). That page does not name sermorelin. It is context for asking where a peptide comes from, not a finding about sermorelin.

What does independent research say about the results people describe?

The 2026 Frontiers review places sermorelin in a tier it labels A*, defined as historical regulatory approval with no current regulatory approval for performance or body composition indications. It describes the human evidence as phase I and II studies in adult endocrine testing and use in children with idiopathic growth hormone deficiency, and it reports no sample sizes for sermorelin human trials. It lists reported adverse effects of injection site pain, short-term flushing, nausea, dizziness and headache, rare allergic reaction and a small, transient rise in prolactin, and it notes there are no long-term safety data. It also says real-world use is complicated by quality-control uncertainty and variable composition in unregulated peptide supply chains. That last point is about unregulated peptide products in general, so it does not describe every pharmacy. For side effects in more detail, see my sermorelin side effects page.

The same review addresses stories shared in online communities. It says off-label use is commonly framed as a physiologic way to raise growth hormone pulses for body composition goals, and that protocols posted on forums are anthropological and behavioral data, not evidence-based treatment strategies. In plain terms, a patient who copies a protocol from a forum thread is following another patient’s story, not a tested plan.

The table below shows what a testimonial can and cannot establish about the claims you will see most often.

Claim in a testimonial	What the story can show	What it cannot show
“I sleep better”	That one person felt differently about sleep	Whether sermorelin, expectation (the placebo effect) or other changes caused it
“More energy and faster recovery”	A self-reported feeling at one point in time	A comparison with people given a placebo, or any baseline measurement
“Lost fat, gained muscle”	A before and after photo or a scale number	What else changed, and whether the result is typical; the Frontiers review says benefits in healthy people remain uncertain
“Younger skin, anti-aging”	How someone feels about their appearance	That sermorelin did it; the FTC says anecdotes are never sufficient to substantiate a health effect claim
“It worked in a few weeks”	One person’s timeline	What most people experience; the sources read for this page do not report a timeline for healthy adults

How should you read a sermorelin before and after photo?

Ask who the person is and whether they were paid or given a discount, because the FTC says a material connection should be disclosed clearly. Ask how long the gap was between the photos and what else changed in that time. Ask what a typical patient experiences, since the FTC says an exceptional result needs proof it is typical, or the ad must state the generally expected result. And ask whether the clinic published any measurement for its sermorelin patients, such as lab results or a study, alongside the photos. A photo alone is not a measurement.

What should you ask a clinic that shows sermorelin testimonials?

Use this checklist. Each question ties to a rule or a finding from the sources above.

Question to ask	Why it matters
Are these testimonials from real patients, and were they paid, discounted or otherwise rewarded?	The FTC requires clear and conspicuous disclosure of connections a significant minority of consumers would not expect, and bars fake reviews
What does a typical patient experience, and where is that published, including any baseline and follow-up IGF-1 levels?	The FTC says dramatic results need proof they are typical, and a “results not typical” note does not cure a misleading claim
Is the product FDA-approved or compounded, and which pharmacy makes it?	The FDA says compounded drugs are not FDA-approved and are not verified for safety, effectiveness or quality before marketing
Which human studies support the claim, and who was enrolled?	The 2026 review calls the human evidence limited and largely indirect for healthy people
What follow-up and lab testing do you use, such as IGF-1 levels, and what happens if I have side effects?	Reported effects include injection site pain, flushing, nausea, dizziness, headache and a transient prolactin rise, and there are no long-term safety data
Do you show negative reviews too?	The FTC rule bars intimidation and unfounded legal threats meant to remove or change reviews

If you are comparing options for weight, my guides to best peptides for weight loss and GLP-1 weight loss cover what each one has and has not been studied for.

Please talk to your prescriber or pharmacist before starting any peptide. This page is a guide to reading marketing, not advice about your treatment.

Frequently Asked Questions

Are sermorelin testimonials reliable?

They are reliable as a record of what one person said, not as proof that sermorelin caused the change. The FTC says anecdotal evidence is never sufficient to substantiate claims about the effects of a health product, and NCCIH describes how expectation alone can produce a beneficial outcome.

Can before and after photos prove sermorelin works?

No. A photo cannot show what else changed, whether the person is typical, or whether anyone was paid. The FTC says an exceptional result needs proof it is typical or a clear statement of the generally expected result.

Are paid or fake sermorelin reviews allowed?

Fake or false consumer reviews and testimonials are barred by the FTC’s rule that took effect October 21, 2024, and certain insider relationships must be disclosed clearly. Real endorsers who were paid or given something of value should have that connection disclosed too, under the Endorsement Guides.

Is sermorelin FDA approved?

The brand Geref was approved for children with growth failure from idiopathic growth hormone deficiency and for a diagnostic test, and approval was withdrawn effective June 18, 2009 at the maker’s request. The FDA found it was not withdrawn for safety or effectiveness. The FDA also says compounded drugs are not FDA-approved.

Do sermorelin results really show up in weeks or months?

Testimonials often name a number of weeks or months for better sleep, energy or skin, but the sources read for this page do not report a timeline for healthy adults, and the 2026 review calls the evidence of meaningful benefit in healthy people uncertain. Treat any timeline in a story as one patient’s experience, not a promise about growth hormone, IGF-1 levels or body composition.

What is the best question to ask before starting?

Ask what the typical patient experiences, with a baseline and follow-up measurement, and where that result is published. A clinic that can point to a study, a lab measurement and a named pharmacy is giving you something a testimonial cannot.

Sources

Sermorelin Testimonials: How to Read Patient Stories and Before and After Claims